Evidence map›Paper›PMID 35153329›Full record

ArticleJournal of food science and technology2022

Cocoa extract with high content of flavan 3-ols, procyanidins and methylxanthines.

Elly Acosta-Otálvaro, Wilmar Valencia-Gallego, Juan Camilo Mazo-Rivas, Cristina García-Viguera

Abstract read
In one paragraph

Article in Journal of food science and technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Profile of Bioactive Components of Cocoa (Foods (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Foods (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elly Acosta-OtálvaroCentro de Investigación Desarrollo y Calidad CIDCA, Compañía Nacional de Chocolates S.A.S, Km 2 Vía Belén Autopista Medellín-Bogotá, Rionegro Antioquia, Colombia.ORCID 0000-0003-4897-6478
Wilmar Valencia-GallegoCentro de Investigación Desarrollo y Calidad CIDCA, Compañía Nacional de Chocolates S.A.S, Km 2 Vía Belén Autopista Medellín-Bogotá, Rionegro Antioquia, Colombia.
Juan Camilo Mazo-RivasCentro de Investigación Desarrollo y Calidad CIDCA, Compañía Nacional de Chocolates S.A.S, Km 2 Vía Belén Autopista Medellín-Bogotá, Rionegro Antioquia, Colombia.
Cristina García-VigueraLaboratorio de Fitoquímica y Alimentos Saludables, Departamento de Ciencia y Tecnología de Alimentos, CEBAS-CSIC, Campus Universitario de Espinardo 25. 30100 Espinardo, Murcia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The health benefits of cocoa depend on the flavan 3-ols, procyanidins, and methylxanthines, which decrease from the early stages of cocoa bean processing. The objective of this research was to obtain a cocoa extract high in these compounds with (-)-epicatechin as the primary reference. An evaluation of two pretreatments of cocoa beans with a control after harvesting was made: A (untreated/control), B (Frozen), and C (Polyphenol oxidase inhibition), all followed by dehydration at 45 °C until obtaining a cocoa powder. In terms of (-)-epicatechin content, the best pretreatment was put on to a hydroalcoholic extraction. Flavan 3-ols, procyanidins, methylxanthines, and total polyphenols content (TPC), were quantified in the cocoa powders and the hydroalcoholic extract. The results showed that the control (A), significantly conserves the (-)-epicatechin (24.964 ± 0.400 mg/g) ca. 7 times more than conventionally sun-dried and fermented beans (3.742 ± 1.977 mg/g) ca. The hydroalcoholic extraction increased the (-)-epicatechin ca. 3 times more based on pretreatment A (84.738 mg/g).

Indexed as

CocoaEpicatechinFlavan 3-olsHydroalcoholic extract

Identifiers

PMID35153329
PMCPMC8814059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.